Investor
Relations

Inspire. Grow. Care.

Explore our Deck

Find the company overview and discover with us exciting scientific developments and business opportunities.

From the CEO's desk:
Vertical integration

Periodic updates and perspectives on various aspects of our business.

Our Research

IGC-AD1

Is designed to target neuroinflammation, potentially stabilize CB1r function and address neurotransmitter imbalances, all hallmarks associated with agitation in Alzheimer Dementia

TGR-63

A small molecule designed to break down plaque formation in the brain, exhibiting outstanding biocompatibility, the ability to breach the blood–brain barrier, and pre-clinical behavioral efficacy.

A.I.

To mine the depths of decades-worth of Alzheimer’s research, bringing to light novel insights and pioneering advanced treatments faster than ever for a healthier elderliness.

Science

IGC Pharma is actively building a portfolio of both plant-derived and manufactured molecules that can address multiple areas of unmet medical needs.

Locations

Our company has operations in different countries
manufacturing vertical and R&D capabilities.